Genetic Analysis AS
Research Genetic Analysis AS (GEAN) on Bullrun: market cap NOK 46.01M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGEAN
- ExchangeST
- CountryNorway
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyNOK
- Market capNOK 46.01M
- Financial periodQ4 2025
- RevenueNOK 6.35M
- Net income-NOK 2.59M
- Free cash flowNOK 6.67M
- Gross margin68.4%
Valuation Snapshot
latest market cap is NOK 46.01M.
About Genetic Analysis AS
Genetic Analysis AS, a science-based diagnostic company, engages in the research, development, manufacturing, and sale of diagnostic test solutions for human microbiome in the United States, Europe, and internationally. The company offers GA-map MHI Gut Health Test, a microbiome-based diagnostic test for antibiotic-induced microbiome imbalances; GA-map Dysbiosis Test, a diagnostic microbiome test that detects and characterizes dysbiosis; GA-map Discovery, a microbiome research assay;
Frequently asked questions
What is Genetic Analysis AS's market cap?
Genetic Analysis AS's market capitalization is NOK 46.01M.
What does Genetic Analysis AS do?
Genetic Analysis AS, a science-based diagnostic company, engages in the research, development, manufacturing, and sale of diagnostic test solutions for human microbiome in the United States, Europe, and internationally.